CONCLUSION
The association between use of Olanzapine and occurrence of episodes of
hyponatremia has been reported quite frequently in the literature, as
has rhabdomyolysis. They do not seem to be correlated with any risk
factor or toxic dose and their occurrence is sporadic. Similarly, the
concomitant occurrence of these two complications in the same patient
remains exceptional.
Their diagnosis remains of elimination, but this does not delay
treatment which is mostly symptomatic.